Singapore eDevelopment subsidiary Global BioLife’s 3F Antimicrobial Fragrance shows Efficacy against Tuberculosis
Singapore eDevelopment Ltd (SeD) is pleased to announce that its U.S. biomedical subsidiary Global BioLife Inc. has developed 3F Antimicrobial Fragrance, which shows efficacy against tuberculosis. Tuberculosis is the leading cause of deaths from a single infectious agent, infecting about one quarter of the